Buy Tesamorelin Peptide in Australia
Buy Tesamorelin in Australia from Macropus Peptides in 2mg, 5mg, 10mg and 20mg vials, all priced and ready to order. Tesamorelin is the complete 44 amino acid sequence of human growth hormone releasing hormone with a small fatty acid cap on its first amino acid, a change that blocks the enzyme which normally disables GHRH within minutes. It has one of the deepest clinical literatures of any GHRH analogue, including phase 3 trials published in leading journals. The 20mg vial gives the lowest price per milligram, the 2mg vial suits method work, and the 5mg vial also comes in a starter kit. Each vial holds lyophilised powder under a crimped seal and a label showing compound, strength, lot and storage temperature, and the certificate of analysis for that lot is sent on request. A Tesamorelin and Ipamorelin blend is stocked too. Add bacteriostatic water and the order ships from Australia nationwide, to adults 18 and over, for in-vitro laboratory research only and not for human or veterinary use.
| Compound | Tesamorelin |
|---|---|
| Amount | 2 mg |
| Form | Lyophilised powder |
| Category | Growth hormone research |
| Storage | -20 °C, protect from light |
| Testing | HPLC purity 98% or higher and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
Tesamorelin 2mg vial
Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.
Buy Tesamorelin Australia: 2mg, 5mg, 10mg and 20mg Vials
Macropus Peptides lists this peptide in four priced fills, from a 2mg vial for method work through 5mg and 10mg to a 20mg vial for long projects, all supplied as research-grade lyophilised powder. It is the full-length, DPP-4 resistant analogue of growth hormone releasing hormone, and each lot is released on its own certificate. Whichever fill you choose, the peptide inside is identical; only the quantity and the unit cost change.
Tesamorelin Australia: what the peptide is
Growth hormone releasing hormone is a 44 amino acid peptide made by the hypothalamus. This analogue keeps all 44 of them, unlike the shorter 1-29 analogues, and adds a trans-3-hexenoyl group, a six-carbon fatty acid, to the tyrosine at position 1. That cap blocks DPP-4, the enzyme that removes the first two amino acids of natural GHRH and switches it off. The molecule weighs about 5,136 daltons, around one and a half times the mass of a 1-29 fragment. The result is a GHRH analog that behaves like the natural hormone at the receptor but survives long enough to study. United States regulators licensed it in 2010 for one narrow indication; Australia has no registration for it.
How the GHRH analog works in research
Its target is the GHRH receptor on somatotrophs, the anterior pituitary cells that make growth hormone. Through the Gs protein and cyclic AMP, the receptor drives growth hormone production and release, and the hormone then prompts the liver to raise IGF-1. Because the release still follows the pituitary's own rhythm and remains subject to feedback from somatostatin and IGF-1, the peptide is used to study a stronger but still physiological growth hormone axis. Research has focused on how that axis links to visceral fat, liver fat and lipid handling, and on the brain, where growth hormone and IGF-1 also act.
It is often searched against Ipamorelin, but the two act on different receptors. This one is a GHRH receptor agonist; the pentapeptide activates the ghrelin receptor. One raises cyclic AMP in the somatotroph, the other raises calcium, and studies that combine them look at how the two signals add together. Within the GHRH class it is the full-length option, while CJC-1295 no DAC is the stabilised 1-29 fragment and its DAC cousin the albumin-bound, days-long version.
Tesamorelin clinical research: what the studies show
Few GHRH analogues have a clinical record this large. A 2007 phase 3 trial (New England Journal of Medicine) measured visceral fat, lipids and glucose markers in adults with HIV and abdominal fat accumulation. A pooled analysis of two phase 3 trials, with extension data, was published in 2010 (Journal of Clinical Endocrinology and Metabolism) and measured body composition and IGF-1. Archives of Neurology carried a 2012 randomised trial that examined cognitive measures in older adults, some with mild cognitive impairment. In 2014 a randomised trial in JAMA used imaging to measure visceral fat and liver fat content, and a 2019 multicentre trial in The Lancet HIV followed liver fat fraction and fibrosis measures. Each trial's design and endpoints appear in our GHRH analogue research studies library.
Tesamorelin vial specifications
| Specification | Detail |
|---|---|
| Compound | Tesamorelin |
| Amount | 2 mg |
| Form | Lyophilised powder |
| Category | Growth hormone research |
| Storage | -20 °C, protect from light |
Each fill is a white lyophilised solid in a glass vial with a butyl stopper and flip-off crimp cap. Labels show the compound, the milligrams inside, a lot identifier and the recommended storage temperature. Provide the lot identifier and we send the certificate of analysis that matches it. Hold unopened vials frozen at -20 °C, boxed against light, until reconstitution, then move the mixed vial to a 2 to 8 °C fridge.
Tesamorelin price: four fills in Australian dollars
| Strength | Price | Price per mg |
|---|---|---|
| Tesamorelin 2mg | $63.99 | $32.00 per mg |
| Tesamorelin 5mg | $89.99 | $18.00 per mg |
| Tesamorelin 10mg | $159.99 | $16.00 per mg |
| Tesamorelin 20mg | $199.99 | $10.00 per mg |
Every fill carries a fixed Australian dollar price, and the cost per milligram falls at each step up. The 2mg vial is the dearest per milligram and the smallest commitment. The 10mg vial costs less than two 5mg vials, and the 20mg vial costs well under two 10mg vials, making it the lowest unit price in the range. For studies that also need the ghrelin-side signal, the 13mg and 3mg blend with Ipamorelin is priced level with the 10mg vial yet holds more of this peptide, which makes it the cheapest route per milligram when both compounds are wanted.
Tesamorelin 10mg: the reference vial
The 10mg vial is our reference size: priced, stocked and large enough to keep most protocols on one lot from start to finish. Two millilitres of diluent give a concentrated 5 mg per mL stock, while five give a milder 2 mg per mL. A 4 mL reconstitution sits between the two at 2.5 mg per mL, the same strength the 5mg vial reaches in 2 mL.
Tesamorelin 20mg: the best price per milligram
With double the reference content, the 20mg fill keeps a long or multi-arm project on one lot, removing lot change as a variable, and it is the cheapest way to buy this peptide by the milligram. Reconstituted in 4 mL it lands at 5 mg per mL, level with the 10mg fill in 2 mL; in 2 mL it makes a dense 10 mg per mL stock for laboratories that dilute further at the bench.
Tesamorelin 5mg: the smaller fill and starter kit vial
Half the reference vial, the 5mg fill covers a brief run, a single comparison arm or method work in a new assay. One millilitre of diluent gives 5 mg per mL, two give 2.5 mg per mL, and two and a half give an even 2 mg per mL. Laboratories without supplies can take the Tesamorelin starter kit, where this fill is boxed with bacteriostatic water (3 mL), ten syringes and twenty swabs.
Tesamorelin 2mg: the smallest vial to order
The smallest fill serves pilot work: a first solubility test, a trial of a new assay or a single short comparison arm. Dissolved in 1 mL it reads 2 mg per mL; in 2 mL, a round 1 mg per mL. It costs the most per milligram of the four, so it is chosen for its small commitment rather than its value.
Best place to buy Tesamorelin in Australia
- Sold online at macropuspeptides.com in 2mg, 5mg, 10mg and 20mg, priced from $63.99
- Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
- A certificate of analysis for every lot, matched to the lot number printed on the label
- Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
- Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
- Payment by PayID or bank transfer, with your order ID as the reference
Buy Tesamorelin online: step by step
- Choose the 2mg, 5mg, 10mg or 20mg fill
- Set the vial quantity
- Add bacteriostatic water, or take the starter kit instead
- Tick the adult and research declarations as you pay
- Store the lot identifier for any certificate request
Tesamorelin calculator: diluent volumes for each fill
Stock strength is fill over volume: one millilitre over five milligrams makes 5 mg per mL, and doubling the water halves it. Ten milligrams need two millilitres for that same 5 mg per mL (5,000 micrograms in each millilitre) and four for the halved figure. Twenty milligrams reach 5 mg per mL in four millilitres and 10 mg per mL in two, while two milligrams in one millilitre give 2 mg per mL. Matching volumes that way lets a laboratory switch between the two fills and keep the same working concentration. For diluent, add bacteriostatic water; syringes and swabs are grouped under lab supplies and kits.
Is Tesamorelin available in Australia
As a medicine, no. The ARTG has no entry for it and the TGA has not approved it, which bars its supply here for human or veterinary purposes. As a research chemical, yes: bench and in-vitro laboratories are the customers we ship it to. The TGA schedules releasing factors for growth hormone through the Poisons Standard; read the current edition against your organisation's approvals.
Tesamorelin for sale Australia wide: shipped from onshore stock
Parcels go from local Australian stock to universities, institutes and private laboratories in Canberra, Perth, Melbourne, Darwin, Sydney, Adelaide, Brisbane, Hobart and regional towns, with no import step. It sits in our growth hormone research range alongside Ipamorelin, the long-acting CJC-1295 with DAC and the combination vials.
References
- Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine. 2007.
- Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. Journal of Clinical Endocrinology and Metabolism. 2010.
- Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Archives of Neurology. 2012.
- Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014.
- Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. The Lancet HIV. 2019.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.